CALADRIUS BIOSCIENCES, INC.

Company

LISATA THERAPEUTICS, INC.

Filed

February 18, 2021

Accession Number

0000902664-21-001481

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →